Focus on our Future

From 2009.igem.org

(Difference between revisions)
Line 1: Line 1:
 +
<html>
 +
<body style="background-color:#006380">
 +
 +
<html>
 +
<div align="center"><a href="https://2009.igem.org/Team:METU-Gene/Events_in_Wound_Dressing"><img src="https://static.igem.org/mediawiki/2009/d/d4/Events_in_WDk.gif"
 +
    style="width:15%; height:150px; border:2px solid #aaa; margin:-10px 5px 10px 15px;"
 +
          title="Events in Wound Dressing">
 +
<a href="https://2009.igem.org/Team:METU-Gene/Working_Mechanism"><img src="https://static.igem.org/mediawiki/2009/b/b5/Workingmechk.gif"
 +
    style="width:15%; height:150px; border:2px solid #aaa; margin:-10px 5px 10px 0px;"
 +
          title="Working Mechanism">
 +
<a href="https://2009.igem.org/Team:METU-Gene/Methods_and_Results"><img src="https://static.igem.org/mediawiki/2009/6/6f/METHODSANDRESULTSk.jpg"
 +
    style="width:15%; height:150px; border:2px solid #aaa; margin:-10px 5px 10px 0px;"
 +
          title="Methods and Results">
 +
<a href="https://2009.igem.org/Index-4.html"><img src="
 +
https://static.igem.org/mediawiki/2009/2/25/MODELLingk.gif"
 +
    style="width:15%; height:150px; border:2px solid #aaa; margin:-10px 5px 10px 0px;"
 +
          title="Modelling of Mechanism">
 +
<a href="https://2009.igem.org/2009.igem.org/metu-gene/parts"><img src="https://static.igem.org/mediawiki/2009/6/6a/Ads%C4%B1zk.jpg"
 +
    style="width:15%; height:15%; border:2px solid #aaa; margin:-10px 5px 10px 0px;"
 +
          title="Constructed Devices">
 +
<a href="https://2009.igem.org/Team:METU-Gene/Focus_on_our_Future"><img src="https://static.igem.org/mediawiki/2009/f/f7/Focus_Logoy.jpg"    style="width:150px; height:150px; border:4px solid #aaa; margin:-10px 5px 10px 0px;"
 +
    title="Focus on our Future!"></a></div></html>
 +
 +
 +
----
 +
 +
 +
<br>(1)'''Testing hEGF, Hkgf and Granulysin proteins in vivo'''
<br>(1)'''Testing hEGF, Hkgf and Granulysin proteins in vivo'''

Revision as of 22:54, 21 October 2009




(1)Testing hEGF, Hkgf and Granulysin proteins in vivo


After proving the correct working project system, we plan to see the effects and outcomes of the project in vivo.



(2)Adding some mechanisms of wound healing such as interleukins and other growth factors


For example,Thymosin beta 4 which consists of 68 a.a accelerated skin wound healing in a rat model of a full thickness wound where the epithelial layer was destroyed. When Tb4 was applied topically to the wound or injected into the animal, epithelial layer restoration in the wound was increased 42% by day four and 61% by day seven, after treatment, compared to untreated. Furthermore, Tb4 stimulated collagen deposition in the wound and angiogenesis. Tb4 accelerated keratinocyte migration, resulting in the wound contracting by more than 11%, compared to untreated wounds, to close the skin gap in the wound. An analysis of skin sections (histological observations) showed that the Tb4 treated wounds healed faster than the untreated. Proof of accelerated cell migration was also seen in vitro, where Tb4 increased keratinocyte migration two to threefold, within four to five hours after treatment, compared to untreated keratinocytes.



(3)Testing the wound healing mechanism timeline


(4)Testing the whole genetic circuit of EGF synthesizing and KGF synthesizing bacteria coloniesAdding genomic


(5)integration method to increase yield of proteins


(6)Embedding the very useful beta-4 protein to our system

Retrieved from "http://2009.igem.org/Focus_on_our_Future"